Navigation Links
Potential New Cancer Gene Identified

A Johns Hopkins University research team has discovered a new family of genes that contributes to the process of malignancy, shedding new light on the abnormalities that give rise to the aggressive childhood cancer, Burkitt's lymphoma - as well as lymphoma, leukemia, prostate, ovarian, lung, and breast cancer.

Characterized by rapidly growing abdominal tumors, Burkitt's lymphoma is one of the three major types of pediatric non-Hodgkin's lymphomas, representing 40% of that group. According to the American Cancer Society, aproximately 57,000 children are diagnosed with non-Hodgkin's lymphoma per year in the United States, representing about 6% of cancers in children. While aggressive, Burkitt's lymphoma responds well to chemotherapy, and has a 90% survival rate if the tumor has not spread beyond the abdomen.

Scientists have long known that the "myc" family of genes plays a prominent role in tumor formation, also called neoplastic transformation. The Hopkins team, focusing on c-myc, found that another gene called the HMG-I/Y gene is a key genetic "target" necessary for Myc-mediated transformation.

When the expression of this target gene in Burkitt's lymphoma cell lines was blocked, the cancer cells revert back to normal-appearing cells. This could point the way to new therapies for one of the most aggressive childhood cancers, as well as other cancers associated with increases in the HMG-I/Y gene according to the Johns Hopkin's research team.
'"/>




Page: 1

Related medicine news :

1. Lack of Smell And Its Potential Risks
2. New Blood Thinner Pill - First Potential Alternative to Warfarin in 50 years
3. The Potential Of Cadaver Transplantation Programme In India
4. Another Potential Of Stem Cells Discovered: Used For Growing Cartilage
5. Yoga Guru Ramdev Invited to Tap Ayurveda Potential by Jharkhand Govt
6. A Protein In Yoghurt Has The Potential To Fight E. coli
7. Gold Therapy- A Potential Treatment For Autoimmune Diseases
8. Whirlpool Bath Tubs Contain Potentially Lethal Bacterial Strains
9. Potential Benefits Of New Nanotechnology
10. Hormone Can Foretell Presence Of Potentially Fatal Pulmonary Hypertension
11. UC Researchers Find Potential Drug Target For SARS

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Potential New Cancer Gene Identified

(Date:11/8/2009)... UCW Academy of Health holds open ho...Victoria, BC (Vocus) November 8, 2009 -- UCW Acade...eer in British Columbia’s health care indust...sday, November 25, 2009. , ,UCW Academy of Health...ation, nursing and social services, designs its pr...
(Date:11/8/2009)... New book called "Preventing an... Dr. Roberto Giraldo shows that AIDS is a result o...iety of so-called immune system stressor agents, w... and most of all, emotional. , ...m Nov. 6 – 8, 2009, cell biologists, physici...
(Date:11/8/2009)...NGTON, Nov. 7 Today, th...s, Kaptur, Dahlkemper, Smith, Ellsworth and Lipins...erica Act" (H.R. 3962). The amendment maintains th... abortion and for benefits packages that include a... who receive affordability credits and those who d...
(Date:11/8/2009)...s for Swift Passage of H.R. 3961 to Secure the Sta...ire-USNewswire/ -- Statement Attributable to: J. J...ociation. ,, (Logo: http://www.newscom.com/cg...ls the passage of the House health reform bill, wh...ts and physicians and calls for swift passage of H...
(Date:11/8/2009)...WOOD, Calif., Nov. 8 Ma...of Babies luncheon to recognize prominent individu...n and who are role models for March of Dimes commi... the March of Dimes November Prematurity Awareness...re urged to join the fight for preemies! ,, (Ph...
Breaking Medicine News(10 mins):Health News:College Invites Public to Explore Career Options in Health Care 2Health News:Revolutionary New Views on AIDS Highlight the Rethinking AIDS 2009 Congress; Emotional Issues can be a Significant Contributing Factor 2Health News:Revolutionary New Views on AIDS Highlight the Rethinking AIDS 2009 Congress; Emotional Issues can be a Significant Contributing Factor 3Health News:Family Research Council Praises Passage of Pro-life Amendment to Health Care Bill 2Health News:AMA Hails House Passage of Health Reform Bill (H.R. 3962) 2Health News:Hollywood Stars Joined in a Celebration of Babies 2Health News:Hollywood Stars Joined in a Celebration of Babies 3
...munochemical faecal occult blood test (FOBT) is a ...ave colorectal cancer, researchers claim in an art...nventionally, guaiac FOBT is used to screen indivi...rectal cancer." Lead author Dr Callum G Fraser ...
...nd more youth belonging to Himachal Pradesh are co...f stress and changing lifestyles.// In the year 20...e by consuming poison, according to sources from t...254 last year," said J.R. Gaur, Director of the Hi...
...l and surgical services provided by NHS could suff...unties (Surrey and Sussex) failed to improve, warn...k financial management, in addition to lack of pro...th care trusts and hospitals is believed to reach ...
...spase-8 gene prevents the metastasis of the neurob...hildren's Research Hospital and the University of ... that have broken itself from the main primary tum... to all tumors present in the nervous system. It i...
...rus which causes severe diarrhea can be combated w.... The New England Journal of Medicine has publishe... much as by between 85% to 100%. The affliction af...ajor step towards getting them put into wider use....
...a: The Bird Flu outbreak is threatening to cause a...very crucial to contain the spread, according to t...burizal Bakrie. The Nation’s Economic Minister, eq...mic. The consequences would be extremely grave...
Other Medicine News:Health News:NHS Audit Commission Warns Possible Financial Collapse In Sussex And Surrey 2Health News:Metastasis of Neuroblastoma linked to Loss Of Caspase-8 gene 2
(Date:11/6/2009)...AN DIEGO, Nov. 6 Trius Therapeutic...ration statement on Form S-1 with the U.S. Securit...oposed initial public offering of shares of its co...old in the offering will be offered by the Company...ng as sole book-running manager, Piper Jaffray &am...
(Date:11/6/2009)...ARASOTA, Fla., Nov. 6 R...ed that it has signed a definitive agreement to ac...etary medical devices. The Verathon Board of Dire... is subject to customary regulatory approvals and .... The parties expect the closing to be completed ...
(Date:11/6/2009)...RINCETON, N.J., Nov. 6 ..., a provider of advanced wound care products, anno...lts before market on Monday, November 16, 2009. Th...y to discuss the results at 11:00 am EST. Interest...r (857) 350-1684 (international), with passcode 81...
Breaking Medicine Technology:Roper Industries Announces Two Acquisitions to Enhance Growth in Medical and Toll & Traffic Businesses 2Roper Industries Announces Two Acquisitions to Enhance Growth in Medical and Toll & Traffic Businesses 3Derma Sciences Announces Date of Its Third Quarter 2009 Earnings Release and Conference Call 2What Oklahomans Should Know About Cataract Surgery 54775 1What Oklahomans Should Know About Cataract Surgery 54775 2What Oklahomans Should Know About Cataract Surgery 54775 3What Texans Should Know about Cataract Surgery 54773 1What Texans Should Know about Cataract Surgery 54773 2What Texans Should Know about Cataract Surgery 54773 3Aurora Biofuels Breakthrough Doubles CO2 Uptake and Fuel Production 13617 1Aurora Biofuels Breakthrough Doubles CO2 Uptake and Fuel Production 13617 2
...mpany to host a conference call Monday, March 10, ...aceuticals,Inc. (Nasdaq: KERX ) today announced t...l trial of Sulonex (sulodexide) for the treatment ...t this Phase 3 clinical,trial failed to meet the p...se the proportion of patients that achieve therape...
...RGO, Fla., March 7 AlphaMed Pharmaceuticals,Corpo...sfully expressed a,humanized version of the therap...scientists expressed their recombinant AAT utilizi...yeast. The yeast has been genetically,altered to p...ich is,manufactured by the human body., "This mar...
Other Medicine Technology:Keryx Biopharmaceuticals Announces that the SUN-MICRO Phase 3 Clinical Trial Failed to Meet its Primary Efficacy Endpoint 2Keryx Biopharmaceuticals Announces that the SUN-MICRO Phase 3 Clinical Trial Failed to Meet its Primary Efficacy Endpoint 3Keryx Biopharmaceuticals Announces that the SUN-MICRO Phase 3 Clinical Trial Failed to Meet its Primary Efficacy Endpoint 4AlphaMed Pharmaceuticals Announces Breakthrough in the Development of Recombinant Alpha 1-Antitrypsin 2
A to Z Drug Facts, 6th Edition
2006 Lippincott's Nursing Drug Guide
...M-8 loads and unloads two centrifuges with primary...cation via Cap Recognition the tube type is determ...5 position racks into the centrifuges. Alternative...an be offered for laboratories with a smaller amou...
... different specimen in one run. Complex scanning a...l samples are sorted, decapped and archived in a v...g given sorting priorities. Optionally a Tube Type... Module can be integrated. Selectively decapping i...
Medicine Products: